NewsFlash Archive

more Events

Subscribe

  • 0%
    0 votes

    Living With a Rare Genetic Disease

    Thursday, July 29, 2010

    "It's a horrible disease reallyThese were the words of Ballymahon native Tom Colohan when he was explaining the condition he suffers from - Friedrich's AtaxiaA rare genetic condition, Friedrich's Ataxia is present from birth but doesn't develop until later in life. It generally develops between t

    read more>>

  • 0%
    0 votes

    Glendive Girl Represents MT in Washington, DC

    Friday, June 11, 2010

    Billings -- A Glendive girl with a rare genetic disease is representing Montana in Washington DCAbryanna Nelson, 11, was treated at Shodair Children's Hospital in Helena for an inherited disease called Friedreich's ataxia. Shodair is one of 170 Children's Miracle Network hospitals in the country

    read more>>

  • 0%
    0 votes

    Family of Local Boy Raises Money to Benefit Others

    Tuesday, May 25, 2010

    As a young child, Sam Brown's mother said the family never suspected anything was seriously wrong with their childHis frequent falls were attributed to him being "a little on the clumsy side," she said. However, as he grew older and his gait problems became more noticeable Lee Anna Brown and her h

    read more>>

  • 0%
    0 votes

    Repligen Receives Orphan Drug Designation From the FDA for RG2833 for Friedreich's Ataxia

    Tuesday, May 25, 2010

    WALTHAM, Mass. -- Repligen Corporation (Nasdaq: RGEN) announced today that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted orphan drug designation to RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitor for the treatment of Friedreich's ataxia

    read more>>

  • 0%
    0 votes

    Repligen Files Investigational New Drug Application With FDA for First Drug Targeting the Core Genetic Defect of Friedreich's Ataxia

    Monday, May 17, 2010

    WALTHAM, Mass. -- Repligen Corporation (Nasdaq: RGEN) announced today that it has filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) for a Phase 1 study of RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitorThis is a double-blind, single ascend

    read more>>

  • 0%
    0 votes

    Brave Sam Travels to USA for Treatment of Crippling Illness

    Thursday, May 6, 2010

    A Dublin family are travelling to America in the hopes that a specialist will assist their young son who has a crippling diseaseSam McMahon (8) suffers from a rare disorder of the nervous system called Friedreich's AtaxiaThe Knocklyon schoolboy is affected by clumsiness, has difficulties with bal

    read more>>

  • 0%
    0 votes

    Mechanism Elucidated for a Rare Disease

    Tuesday, May 4, 2010

    Scientists at the Friedrich Miescher Institute for Biomedical Research (FMI, part of the Novartis Research Foundation) have dissected one of the molecular mechanisms underlying Friedreich's ataxiaIn doing so, they have shed new light on the pathogenic mechanism of the disease. These findings could

    read more>>

  • 0%
    0 votes

    PhRMA Honors Patient Advocates Ron and Raychel Bartek

    Friday, March 19, 2010

    WASHINGTON -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today honored Ron and Raychel Bartek for their dedicated work driving awareness of Friedreich's ataxia, a debilitating, life-threatening, rare diseaseThe Barteks are co-founders of the Friedre

    read more>>

  • 0%
    0 votes

    Disabled St. Albans Schoolboy Skydives for Charity

    Thursday, February 18, 2010

    A thrill-seeking disabled teenager living with a rare genetic disorder will fulfill a life-long dream by leaping out of a plane in aid of a charity close to his heartGlen Shorey, 16, of Corinium Gate, St Albans, has been left wheelchair-bound by his condition, medically dubbed Freidreich's ataxia,

    read more>>

  • 0%
    0 votes

    Excess DNA Damage Found in Cells of Patients With Friedreich's Ataxia

    Friday, January 15, 2010

    PITTSBURGH -- Elevated levels of DNA damage have for the first time been found in the cellular mitochondria and nuclei of patients with the inherited, progressive nervous system disease called Friedreich's ataxia (FRDA), says a multicenter research team led by an expert from the University of The

    read more>>